Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

Similar articles for PubMed (Select 18203836)

1.

Proteomic, microarray, and signature-tagged mutagenesis analyses of anaerobic Pseudomonas aeruginosa at pH 6.5, likely representing chronic, late-stage cystic fibrosis airway conditions.

Platt MD, Schurr MJ, Sauer K, Vazquez G, Kukavica-Ibrulj I, Potvin E, Levesque RC, Fedynak A, Brinkman FS, Schurr J, Hwang SH, Lau GW, Limbach PA, Rowe JJ, Lieberman MA, Barraud N, Webb J, Kjelleberg S, Hunt DF, Hassett DJ.

J Bacteriol. 2008 Apr;190(8):2739-58. doi: 10.1128/JB.01683-07. Epub 2008 Jan 18.

2.

Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis.

Hoboth C, Hoffmann R, Eichner A, Henke C, Schmoldt S, Imhof A, Heesemann J, Hogardt M.

J Infect Dis. 2009 Jul 1;200(1):118-30. doi: 10.1086/599360.

3.

The Pseudomonas aeruginosa universal stress protein PA4352 is essential for surviving anaerobic energy stress.

Boes N, Schreiber K, Härtig E, Jaensch L, Schobert M.

J Bacteriol. 2006 Sep;188(18):6529-38.

4.

Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis.

Yoon SS, Hennigan RF, Hilliard GM, Ochsner UA, Parvatiyar K, Kamani MC, Allen HL, DeKievit TR, Gardner PR, Schwab U, Rowe JJ, Iglewski BH, McDermott TR, Mason RP, Wozniak DJ, Hancock RE, Parsek MR, Noah TL, Boucher RC, Hassett DJ.

Dev Cell. 2002 Oct;3(4):593-603.

PMID:
12408810
5.

Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum.

Palmer KL, Brown SA, Whiteley M.

J Bacteriol. 2007 Jun;189(12):4449-55. Epub 2007 Mar 30.

6.

Transcriptome analyses and biofilm-forming characteristics of a clonal Pseudomonas aeruginosa from the cystic fibrosis lung.

Manos J, Arthur J, Rose B, Tingpej P, Fung C, Curtis M, Webb JS, Hu H, Kjelleberg S, Gorrell MD, Bye P, Harbour C.

J Med Microbiol. 2008 Dec;57(Pt 12):1454-65. doi: 10.1099/jmm.0.2008/005009-0.

7.

Long-term anaerobic survival of the opportunistic pathogen Pseudomonas aeruginosa via pyruvate fermentation.

Eschbach M, Schreiber K, Trunk K, Buer J, Jahn D, Schobert M.

J Bacteriol. 2004 Jul;186(14):4596-604.

8.

Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions.

Yoon SS, Coakley R, Lau GW, Lymar SV, Gaston B, Karabulut AC, Hennigan RF, Hwang SH, Buettner G, Schurr MJ, Mortensen JE, Burns JL, Speert D, Boucher RC, Hassett DJ.

J Clin Invest. 2006 Feb;116(2):436-46. Epub 2006 Jan 26.

9.

Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets.

Hassett DJ, Cuppoletti J, Trapnell B, Lymar SV, Rowe JJ, Yoon SS, Hilliard GM, Parvatiyar K, Kamani MC, Wozniak DJ, Hwang SH, McDermott TR, Ochsner UA.

Adv Drug Deliv Rev. 2002 Dec 5;54(11):1425-43. Review.

PMID:
12458153
10.

Fosfomycin and tobramycin in combination downregulate nitrate reductase genes narG and narH, resulting in increased activity against Pseudomonas aeruginosa under anaerobic conditions.

McCaughey G, Gilpin DF, Schneiders T, Hoffman LR, McKevitt M, Elborn JS, Tunney MM.

Antimicrob Agents Chemother. 2013 Nov;57(11):5406-14. doi: 10.1128/AAC.00750-13. Epub 2013 Aug 19.

11.

Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration.

Alvarez-Ortega C, Harwood CS.

Mol Microbiol. 2007 Jul;65(1):153-65. Erratum in: Mol Microbiol. 2007 Jul;65(2):582.

12.

Two-pronged survival strategy for the major cystic fibrosis pathogen, Pseudomonas aeruginosa, lacking the capacity to degrade nitric oxide during anaerobic respiration.

Yoon SS, Karabulut AC, Lipscomb JD, Hennigan RF, Lymar SV, Groce SL, Herr AB, Howell ML, Kiley PJ, Schurr MJ, Gaston B, Choi KH, Schweizer HP, Hassett DJ.

EMBO J. 2007 Aug 8;26(15):3662-72. Epub 2007 Jul 12.

13.

Oxygen, cyanide and energy generation in the cystic fibrosis pathogen Pseudomonas aeruginosa.

Williams HD, Zlosnik JE, Ryall B.

Adv Microb Physiol. 2007;52:1-71. Review.

PMID:
17027370
14.

Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.

Hassett DJ, Sutton MD, Schurr MJ, Herr AB, Caldwell CC, Matu JO.

Trends Microbiol. 2009 Mar;17(3):130-8. doi: 10.1016/j.tim.2008.12.003. Epub 2009 Feb 21. Review.

PMID:
19231190
15.

Identification of Pseudomonas aeruginosa genes involved in virulence and anaerobic growth.

Filiatrault MJ, Picardo KF, Ngai H, Passador L, Iglewski BH.

Infect Immun. 2006 Jul;74(7):4237-45.

16.

Gene expression characteristics of a cystic fibrosis epidemic strain of Pseudomonas aeruginosa during biofilm and planktonic growth.

Manos J, Arthur J, Rose B, Bell S, Tingpej P, Hu H, Webb J, Kjelleberg S, Gorrell MD, Bye P, Harbour C.

FEMS Microbiol Lett. 2009 Mar;292(1):107-14. doi: 10.1111/j.1574-6968.2008.01472.x.

17.

The anaerobic regulatory network required for Pseudomonas aeruginosa nitrate respiration.

Schreiber K, Krieger R, Benkert B, Eschbach M, Arai H, Schobert M, Jahn D.

J Bacteriol. 2007 Jun;189(11):4310-4. Epub 2007 Mar 30.

18.

Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum.

Fung C, Naughton S, Turnbull L, Tingpej P, Rose B, Arthur J, Hu H, Harmer C, Harbour C, Hassett DJ, Whitchurch CB, Manos J.

J Med Microbiol. 2010 Sep;59(Pt 9):1089-100. doi: 10.1099/jmm.0.019984-0. Epub 2010 Jun 3.

19.

Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections.

Beckmann C, Brittnacher M, Ernst R, Mayer-Hamblett N, Miller SI, Burns JL.

Infect Immun. 2005 Jan;73(1):444-52.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk